Health Canada approves updated Novavax COVID-19 vaccine
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The protein-based vaccine, called Nuvaxovid, targets the JN.1 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant, the agency said in an online update.
1d
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...
Hosted on MSN2mon
Novavax drops as J.P. Morgan cuts to Underweight after recent rallyThe deal led J.P. Morgan to upgrade the stock at the time, as the company received $500M from the French drugmaker as part of the partnership that tied up Nuvaxovid with Sanofi’s (SNY ...
Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the ...
BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback